DeFrancesco Lisa has filed 12 insider transactions across 1 company since February 2025.
Most recent transaction: a option exercise of 128190 shares of LEXICON PHARMACEUTICALS, INC. ($LXRX) on February 28, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 28, 2026 | LEXICON PHARMACEUTICALS, INC. | $LXRX | DeFrancesco Lisa | SVP, IR and Corp Comm | M | Restricted Stock Units | 128190 | $0.00 | 256,380.0000 | 365,780,799 | 33.33% | 0.04% |
| Feb. 28, 2026 | LEXICON PHARMACEUTICALS, INC. | $LXRX | DeFrancesco Lisa | SVP, IR and Corp Comm | M | Common Stock | 24674 | $0.00 | 40,251.0000 | 365,780,799 | 158.40% | 0.01% |
| Feb. 28, 2026 | LEXICON PHARMACEUTICALS, INC. | $LXRX | DeFrancesco Lisa | SVP, IR and Corp Comm | M | Restricted Stock Units | 24674 | $0.00 | 24,673.0000 | 365,780,799 | 50.00% | 0.01% |
| Feb. 28, 2026 | LEXICON PHARMACEUTICALS, INC. | $LXRX | DeFrancesco Lisa | SVP, IR and Corp Comm | F | Common Stock | 74572 | $1.47 | 93,869.0000 | 365,780,799 | 44.27% | 0.02% |
| Feb. 28, 2026 | LEXICON PHARMACEUTICALS, INC. | $LXRX | DeFrancesco Lisa | SVP, IR and Corp Comm | M | Common Stock | 128190 | $0.00 | 168,441.0000 | 365,780,799 | 318.48% | 0.04% |
| Feb. 12, 2026 | LEXICON PHARMACEUTICALS, INC. | $LXRX | DeFrancesco Lisa | SVP, IR and Corp Comm | A | Stock Option (Right to Buy) | 386300 | $0.00 | 386,300.0000 | 365,780,799 | 9999.99% | 0.11% |
| Feb. 12, 2026 | LEXICON PHARMACEUTICALS, INC. | $LXRX | DeFrancesco Lisa | SVP, IR and Corp Comm | A | Restricted Stock Units | 257530 | $0.00 | 257,530.0000 | 365,780,799 | 9999.99% | 0.07% |
| Feb. 28, 2025 | LEXICON PHARMACEUTICALS, INC. | $LXRX | DeFrancesco Lisa | SVP, IR and Corp Comm | M | Common Stock | 24673 | $0.00 | 24,673.0000 | 363,020,303 | 9999.99% | 0.01% |
| Feb. 28, 2025 | LEXICON PHARMACEUTICALS, INC. | $LXRX | DeFrancesco Lisa | SVP, IR and Corp Comm | M | Restricted Stock Units | 24673 | $0.00 | 49,347.0000 | 363,020,303 | 33.33% | 0.01% |
| Feb. 28, 2025 | LEXICON PHARMACEUTICALS, INC. | $LXRX | DeFrancesco Lisa | SVP, IR and Corp Comm | F | Common Stock | 9096 | $0.67 | 15,577.0000 | 363,020,303 | 36.87% | 0.00% |
| Feb. 13, 2025 | LEXICON PHARMACEUTICALS, INC. | $LXRX | DeFrancesco Lisa | VP, IR and Corp Comm | A | Restricted Stock Units | 384570 | $0.00 | 384,570.0000 | 363,020,303 | 9999.99% | 0.11% |
| Feb. 13, 2025 | LEXICON PHARMACEUTICALS, INC. | $LXRX | DeFrancesco Lisa | VP, IR and Corp Comm | A | Stock Option (Right to Buy) | 576850 | $0.00 | 576,850.0000 | 363,020,303 | 9999.99% | 0.16% |